Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sutter

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
Vaccine|October 27, 2012
Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri LankaRajiva de Silva, Sunethra Gunasena, Damayanthi Ratnayake, et al.
The Journal of Infectious Diseases|October 16, 2014
Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trialSubhash Chandir, Kabir U Ahamed, Abdullah H Baqui, et al.
The Pediatric Infectious Disease Journal|August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The New England Journal of Medicine|August 30, 2018
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral VaccineIsobel M Blake, Margarita Pons-Salort, Natalie A Molodecky, et al.
The Journal of Infectious Diseases|June 27, 2019
Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus VaccineSonia Resik, Ondrej Mach, Alina Tejeda, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
The Journal of Infectious Diseases|May 2, 2003
Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trialKathryn A Kohler, Ali Jaffer M Suleiman, Susan E Robertson, et al.
The Journal of Infectious Diseases|March 31, 2010
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in CubaSonia Resik, Alina Tejeda, Pedro Mas Lago, et al.
The Journal of Infectious Diseases|October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study seriesLi Li, Olga Ivanova, Nadia Driss, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Vaccine|October 27, 2012
Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri LankaRajiva de Silva, Sunethra Gunasena, Damayanthi Ratnayake, et al.
The Journal of Infectious Diseases|October 16, 2014
Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trialSubhash Chandir, Kabir U Ahamed, Abdullah H Baqui, et al.
The Pediatric Infectious Disease Journal|August 15, 2017
Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016Imtiaz Hussain, Ondrej Mach, Atif Habib, et al.
The New England Journal of Medicine|August 30, 2018
Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral VaccineIsobel M Blake, Margarita Pons-Salort, Natalie A Molodecky, et al.
The Journal of Infectious Diseases|June 27, 2019
Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus VaccineSonia Resik, Ondrej Mach, Alina Tejeda, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
The Journal of Infectious Diseases|May 2, 2003
Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trialKathryn A Kohler, Ali Jaffer M Suleiman, Susan E Robertson, et al.
The Journal of Infectious Diseases|March 31, 2010
Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in CubaSonia Resik, Alina Tejeda, Pedro Mas Lago, et al.
The Journal of Infectious Diseases|October 16, 2014
Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study seriesLi Li, Olga Ivanova, Nadia Driss, et al.
Vaccine|July 22, 2014
Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infantsPauline Verdijk, Nynke Y Rots, Monique G C T van Oijen, et al.
Pageof 19